TL;DR
This study investigates the prevalence and genetic characteristics of Porcine Pseudorabies Virus (PRV) in Hebei Province, China, between 2017-2018. It reveals a high prevalence of PRV variant strains, which are genetically similar to a strain that has caused human encephalitis, highlighting a significant threat to both the pig industry and public health.
What Problem Does This Paper Address?
Pseudorabies (PR) is a highly contagious and economically devastating disease for the global pig industry, particularly in China. While PRV has historically been managed with vaccines like the Bartha-K61 strain, recent years have seen an increase in PR outbreaks in vaccinated pigs. This suggests the emergence of PRV variant strains that can evade existing vaccine-induced immunity. Understanding the epidemiology of these variant strains, their prevalence, and their genetic makeup is crucial for developing effective control strategies and assessing potential risks to public health, especially given documented cases of human PRV infection. This paper specifically addresses the lack of epidemiological data on PRV in Hebei Province, a significant pig-producing region in China.
Methods
The researchers employed a multi-pronged approach to investigate PRV in Hebei Province:
- Clinical Case Analysis: 693 suspected PRV clinical cases from pigs vaccinated with the Bartha-K61 strain were collected. These cases underwent full clinical autopsy, histopathological examination, and virus isolation.
- Histopathological Examination: Tissues from positive cases were analyzed using Hematoxylin and Eosin (HE) staining to identify pathological lesions. Immunohistochemical (IHC) staining was used to detect PRV antigen in tissues.
- Virus Detection and Isolation: Polymerase Chain Reaction (PCR) was used to detect PRV in tissue samples. For positive samples, virus isolation was performed in a PK-15 cell line, followed by purification and identification via RT-PCR.
- Genetic Analysis: The glycoprotein E (gE) gene of isolated PRV strains was amplified, sequenced, and compared to reference strains using phylogenetic analysis (Cluster W and MEGA7.0.21 software).
- Serological Survey: Enzyme-linked immunosorbent assay (ELISA) was used to detect PRV gE antibodies in 3,449 serum samples collected from pigs across Hebei Province to determine seroprevalence.
Datasets
- Clinical Samples: 693 clinical samples (brain, lung, liver, lymph node, kidney) from suspected PRV-infected pigs in Hebei Province, collected between January 2017 and December 2018.
- Serum Samples: 3,449 serum samples from pigs in Hebei Province, collected between January 2017 and December 2018.
- Reference PRV Strains: Nucleotide and amino acid sequences of gE genes from 19 representative PRV isolates were downloaded from NCBI GenBank for comparative analysis.
Key Insights and Ideas
- Variant Strains are Prevalent: The study confirms that PRV variant strains are highly prevalent in Hebei Province, posing a significant challenge to the pig industry.
- Vaccine Evasion: The fact that these outbreaks occurred in pigs vaccinated with the Bartha-K61 strain highlights the potential for these variant strains to evade existing vaccine-induced immunity.
- Human Health Risk: The genetic similarity of the isolated strains to HSD-1/2019, a strain known to cause human acute encephalitis, raises serious concerns about the potential zoonotic threat of PRV in the region.
- Diverse Pathological Manifestations: PRV infection in Hebei Province presents with a range of severe clinical and pathological signs, including reproductive issues (abortion, stillbirth), neurological disorders, and organ damage (lungs, liver, kidneys).
- Regional Variation in Seroprevalence: The study identified significant differences in PRV antibody prevalence across different cities and farm sizes within Hebei Province, suggesting that localized factors influence disease spread.
Key Results
- gE Gene Detection: Out of 693 suspected PRV cases, 248 (35.78%) tested positive for the PRV gE gene.
- Virus Isolation: 11 PRV variants were successfully isolated and confirmed by gE gene sequencing.
- Genetic Homology: These isolated strains showed high nucleotide homology (97.1%-100.0%) with PRV reference strains, and importantly, clustered with the HSD-1/2019 strain.
- Seroprevalence: The overall seropositivity rate for PRV gE antibodies in 3,449 serum samples was 46.27%.
- Clinical Symptoms: Abortion and stillbirth were the most frequent clinical signs in pregnant sows.
- Histopathological Findings: Typical lesions included nonsuppurative encephalitis, lobar pneumonia, hepatitis, lymphadenitis, and nephritis.
- Geographic Variation: Shijiazhuang city had the highest seropositive rate (59.6%), while Baoding city had the lowest (30.8%).
- Age-Related Prevalence: Growing-finishing pigs showed the highest seropositive rate, followed by nursery pigs and suckling piglets.
Limitations and Future Work
- Study Duration: The study was conducted over a two-year period (2017-2018). The authors acknowledge that PRV is an ongoing challenge, and longer-term monitoring would be beneficial.
- Impact of African Swine Fever: The study's duration was potentially impacted by the African Swine Fever outbreak, which may have influenced sample collection or the overall pig farming landscape.
- Vaccine Efficacy: While the study notes the poor protective effect of current vaccines against new strains, further research is needed to evaluate the efficacy of existing and novel vaccine strategies against these prevalent variant strains.
- Co-infections: The paper mentions that PRV is often coinfected with other viruses, and while some other viruses were tested for, a more comprehensive analysis of co-infections could provide a more complete picture of the disease dynamics.
- Human Health Risk Assessment: While the genetic link to a human encephalitis strain is noted, further epidemiological studies are needed to fully assess the risk of PRV transmission to humans in Hebei Province.
- Prevention and Control Strategies: The authors suggest strengthening feeding management, improving biosafety, and developing suitable immunization programs. Future work should focus on implementing and evaluating these strategies.
Summary updated